Representations and Indemnities to Survive Clause Example from Business Contracts

This example Representations and Indemnities to Survive clause appears in 8 contracts from 7 companies

Representations and Indemnities to Survive. The respective agreements, representations, warranties, indemnities and other statements of the Company or its officers and of the Initial Purchasers set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Initial Purchasers or the Company or any of the indemnified persons referred to in Section 8 hereof, and will survive delivery of and payment for the Securities. The provisions of Sections 7 and 8 hereof ...shall survive the termination or cancellation of this Agreement. View More

Found in Mr. Cooper Group Inc. contract

APi Group Corp Contracts

Purchase Agreement for 4.125% Senior Notes due 2029 (Filed With SEC on August 11, 2021)

Jackson Financial Inc. Contracts

Purchase Agreement dated November 17, 2021 between Jackson Financial Inc. and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as... (Filed With SEC on November 23, 2021)

Vistra Energy Corp. Contracts

Purchase Agreement, dated August 7, 2018, by and among Vistra Operations Company LLC and Citigroup Global Markets Inc., on behalf of itself and the several Initial Purchasers... (Filed With SEC on August 8, 2018)

Nuance Communications, Inc. Contracts

NUANCECOMMUNICATIONS, INC. U.S.$350,000,000 1.25% Senior Convertible Notes Due 2025* Purchase Agreement (Filed With SEC on March 17, 2017)

SemGroup Corp Contracts

SemGroupCorporation $325,000,000 6.375% Senior Notes due 2025 Purchase Agreement (Filed With SEC on March 9, 2017)

Purchase Agreement, dated September 15, 2017, by and among SemGroup Corporation, certain of its wholly-owned subsidiaries party thereto, as guarantors, and Credit Suisse... (Filed With SEC on September 18, 2017)

Mr. Cooper Group Inc. Contracts

WMI HOLDINGS CORP. 600,000 shares of 3.00% Series B Convertible Preferred Stock Par value $0.00001 and liquidation preference $1,000 per share Purchase Agreement (Filed With SEC on December 19, 2014)

Protalix BioTherapeutics, Inc. Contracts

ProtalixBioTherapeutics, Inc. $60,000,0004.50% Convertible Notes Due 2018 PurchaseAgreement (Filed With SEC on September 18, 2013)